Thrombophilic and systemic risk factors in patients with retinal vein occlusion

被引:0
作者
Kuhli-Hattenbach, C. [1 ]
Miesbach, W. [2 ]
Scharrer, I. [3 ]
Hattenbach, L. -O. [4 ]
机构
[1] Univ Frankfurt Klinikum, Klin Augenheilkunde, D-60590 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Abt Hamostaseol, Med Klin 3, Zentrums Inneren Med, Frankfurt, Germany
[3] Univ Frankfurt Klinikum, Abt Hamostaseol, Med Klin 3, Mainz, Germany
[4] Klinikum Ludwigshafen Rhein, Klin Augenheilkunde, Ludwigshafen, Germany
来源
OPHTHALMOLOGE | 2011年 / 108卷 / 02期
关键词
Retinal vein occlusion; Thrombophilia; Resistance to APC; Factor XII deficiency; Cardiovascular risk factors; PROTEIN-C RESISTANCE; FACTOR-XII DEFICIENCY; FACTOR-V-LEIDEN; HIGH PREVALENCE; ABNORMALITIES; THERAPY;
D O I
10.1007/s00347-010-2289-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Over the past years there has been a dramatic increase in the number of identifiable causes of thrombophilia. However, as retinal vein occlusions (RVO) have a strong pathogenic correlation with the presence of hypertension or arteriosclerosis and the average age of affected patients is usually within the sixth or seventh decade of life, thrombophilia screening of RVO patients poses a particularly difficult diagnostic challenge. It is clear that to use medical resources appropriately and improve the level of interdisciplinary patient care in RVO, subgroup analysis is required. Just recently, some studies have demonstrated the significant role of coagulation disorders in specific subgroups of RVO patients and have provided recommendations for clinical practice. These results indicate that thrombophilic risk factors are significantly more prevalent among patients equal or less than 45 years of age at the time of RVO or a previous thromboembolic event, among patients with a remarkable family history of thromboembolism prior to the age of 45 years, or among patients without cardiovascular risk factors. According to these data, thrombophilia screening should be considered in these selected subgroups.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 31 条
[1]  
AbuElAsrar AM, 1997, INT OPHTHALMOL, V20, P197
[2]   Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age [J].
Arsène, S ;
Delahousse, N ;
Regina, S ;
Le Lez, ML ;
Pisella, PJ ;
Gruel, Y .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (01) :101-106
[3]   The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: a Turkish sample [J].
Ates, O. .
CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (06) :391-392
[4]  
De Stefano V, 2002, HAEMATOLOGICA, V87, P1095
[5]  
Dithmar S, 2003, OPHTHALMOLOGE, V100, P561, DOI 10.1007/s00347-003-0820-4
[6]  
Glueck CJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P43
[7]   Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults [J].
Gottlieb, JL ;
Blice, JP ;
Mestichelli, B ;
Konkle, BA ;
Benson, WE .
ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (05) :577-579
[8]   Activated protein C resistance - Low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion [J].
Graham, SL ;
Goldberg, I ;
Murray, B ;
Beaumont, P ;
Chong, BH .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1996, 24 (03) :199-205
[9]   Retinal vascular occlusion and deficiencies in the protein C pathway [J].
Greiner, K ;
Hafner, C ;
Dick, B ;
Peetz, D ;
Prellwitz, W ;
Pfeiffer, N .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (01) :69-74
[10]  
Gris JC, 1997, THROMB HAEMOSTASIS, V77, P1096